Carlos Jiménez‐Vicente

Venetoclax–based low intensity therapy in molecular failure of <i>NPM1</i>-mutated AML

Carlos Jiménez‐Chillón, Jad Othman, David Taussig et al. · Blood Advances · 2023 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients

Tycho Baumann, Riccardo Moia, Gianluca Gaïdano et al. · Leukemia · 2021 · 20 citations

Medicine, Hematology, Oncology +10

Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes

Sandra Castaño‐Díez, Mònica López‐Guerra, Cristina Bosch-Castañeda et al. · Cancers · 2022 · 15 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome

Francesca Guijarro, Mònica López‐Guerra, Jordi Morata et al. · Blood Advances · 2023 · 15 citations · Full text

Life Sciences, Genetics, Hematology +17

Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group

Carlos Jiménez‐Vicente, Paola Charry, Sandra Castaño‐Díez et al. · British Journal of Haematology · 2024 · 13 citations

Medicine, Hematology, Oncology +14